Pharma Marketing Network

OCTOBER 17, 2024

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. With the increasing digitization of healthcare, pharmaceutical companies are leveraging digital platforms to reach broader audiences more effectively.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Scheduling Appointments 52

European Pharmaceutical Review

MARCH 27, 2025

As scientific and pharmaceutical companies grapple to secure the worlds best talent, the science and immigration sectors are aware that the UKs ability to attract global talent in science and technology is constantly under question. 1 Figure 1 : Costs for UK skilled worker visa compared to those of other leading science nations.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling 52

The FDA Law Blog

MARCH 18, 2025

On March 13, 2025, the Federal Circuit ventured into the world of reissued patents and PTE. ( Specifically, the Court focused on the purpose: to compensate pharmaceutical companies for the effective truncation of their patent terms while waiting for regulatory approval of new drug applications. In Merck Sharp & Dohme Corp.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies FDA 59

European Pharmaceutical Review

FEBRUARY 27, 2024

At the time of the announcement, the pharmaceutical company shared that the first Stelara biosimilars are expected to enter the US market in 2025. The post Amgen opens its most advanced manufacturing facility to date appeared first on European Pharmaceutical Review.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies FDA 105

Pharmaceutical Technology

JUNE 7, 2023

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Labelling FDA 98

European Pharmaceutical Review

OCTOBER 6, 2023

There are several benefits of the combination vaccine as a preventative measure against these respiratory conditions, according to the pharmaceutical company. The company reported that a Phase III trial of mRNA-1083 for adults 50 years old and over is set to begin in 2023.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

AUGUST 1, 2022

The DDiCT initiative aligns with the pharmaceutical company’s broader diversity and inclusion goals for 2020-2025, which aim to address health disparities, clinical trial diversity, supplier diversity, employee giving and workforce representation. Efforts to improve clinical trial diversity are ongoing.

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies FDA 122

Pharma Marketing Network

DECEMBER 17, 2021

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Health for Humanity 2025 Goals.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

Pharma Mirror

SEPTEMBER 8, 2021

Marseille, France, Provepharm Life Solutions, a private French pharmaceutical company that finds new applications for well-known molecules, today announces a €120 million ($142.3M) strategic funding. This includes. The post Provepharm Life Solutions raises €120 million appeared first on Pharma Mirror Magazine.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

The Checkup by Singlecare

MARCH 10, 2025

Compounded semaglutide is made by special compounding pharmacies rather than pharmaceutical companies. For those licensed by the state, the deadline is April 22, 2025. For those licensed by the FDA, the deadline is May 22, 2025. A monthly supply of semaglutide ranges from about $129$1,850 without insurance.

Compounding 52

Compounding Insurance Insurance Coverage FDA 52

pharmaphorum

OCTOBER 18, 2021

8 It’s encouraging to see this as one of the goals in the EMA’s 2025 Regulatory Sciences Strategy. What remains very clear is that collaboration between sponsor companies, health authorities and other stakeholders will be required to move this forward. Real-time sharing of data.

Vaccines 143

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 143

European Pharmaceutical Review

DECEMBER 18, 2024

percent (high dose), the pharmaceutical companies reported. Detailed findings of this study are set to be presented at a scientific forum in 2025, according to Sanofi and Teva. For patients with Crohns disease, at week 14, 26.1 percent (low-dose) and 47.8 percent on placebo, 13.0 percent (low dose) and 34.8

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Hospital Pharmacy Europe

MARCH 7, 2024

Many drugs with higher benefit ratings were associated with more significant revenues for the associated pharmaceutical companies, they added. The revenue figures were correlated with the added benefit ratings to analyse the performance of the pharmaceutical company against the benefits of the medications they provide.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

SEPTEMBER 22, 2022

The pharmaceutical company is well on its way to achieving its goals with successful full reimbursements, already confirmed in the United Kingdom ( UK), and Sweden. GlobalData is the parent company of Pharmaceutical Technology.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA Dosage 52

Pharmaceutical Technology

MAY 23, 2023

The recent legislative reform proposals put forward by the European Commission (EC) have sparked significant discontent among pharmaceutical companies. This blog explores the key areas of concern for pharmaceutical companies and some of the potential implications of these reforms.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Packaging 52

Pharmaceutical Technology

OCTOBER 31, 2022

Two categories of novel therapies stand out: cell therapies and therapies with novel MOAs, with new products in each category being forecast to launch between 2023 and 2025. The OA space has long been dominated by large pharmaceutical companies such as Bayer, Pfizer, and Eli Lilly. of the 7MM sales, respectively.

Compounding 59

Compounding Pharmaceutical Companies Pharmaceutical Companies 59

The Thyroid Pharmacist

NOVEMBER 29, 2023

The truth is that most supplement companies do not undergo the same scrutiny and testing that pharmaceutical products do, because many of the tests which are required of pharmaceutical companies are voluntary for supplement companies. We have 270 expiring in March 2025.) We have 299 expiring in March 2025.)

Health and Personal Care Stores 73

Health and Personal Care Stores Immunization Labelling Compounding 73

The Checkup by Singlecare

SEPTEMBER 10, 2024

There have been several biosimilars approved, including Wezlana , Selarsdi, and Pyzchiva, but they are not expected to be available until early 2025. It is made by the pharmaceutical company Amgen, Inc. But Stelara is a biologic product , meaning it will have what’s called a biosimilar instead of a generic version.

FDA 52

FDA Vaccines Specialty Pharmacies Pharmaceutical Companies 52

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies Communication 98

pharmaphorum

OCTOBER 13, 2022

However, patent protection remains in some major markets, including France, Italy, Spain, and the UK until 2025. The question is whether other major pharmaceutical companies will be attracted to the space – particularly when areas such as oncology and orphan drugs currently provide a larger return on investment.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

MAY 10, 2022

Jamie Phares, managing director, The Janssen Pharmaceutical Companies of Johnson & Johnson in the Gulf Cooperation Council (GCC), talks about how the healthcare industry needs to come together to reduce its environmental impact and further protect public health. About the author.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

pharmaphorum

MARCH 12, 2021

Behind all of these are massive and growing volumes of data that life sciences companies generate, manage and analyse to secure breakthroughs. One estimate [1] suggests that by 2025 more than 60 million patients will have their genome sequenced. And those volumes will only increase.

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 111

pharmaphorum

JULY 1, 2021

My SynBioBeta panel discussion was about the shape of biopharma in 2025 – a seemingly futuristic time that’s now less than four years away. Tanja Dowe is the CEO of Debiopharm Innovation Fund, the strategic investment arm of the Swiss pharmaceutical company Debiopharm. About the interviewee.

Pharmaceutical Companies 88

Pharmaceutical Companies Pharmaceutical Companies Patient Care Vaccines 88

Viseven

JULY 16, 2024

Source: Deloitte Combining these types of health data allows pharmaceutical companies to understand a person’s health and genetic profile better, thereby improving the quality of healthcare products and services. Pharma companies deal with enormous amounts of health data. What Is Health Data Management?

Health and Personal Care Stores 52

Health and Personal Care Stores HIPAA Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

MARCH 7, 2024

Lastly, there is growing prominence and interest in radioligand therapeutics within major pharmaceutical companies, who are increasingly investing in this field, evident through recent acquisitions of Point Biopharma and RayzeBio. What makes targeted alpha therapies a promising new approach against cancer?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Immunization FDA 52

pharmaphorum

DECEMBER 21, 2021

By 2025, it is expected that 70 million genomes will be sequenced; a factor that Dr Hackett stated could mean that Rare Diseases “are potentially not as rare as we think…and with this extra information, we’re going to be able to accelerate this field faster.”.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Hospitals FDA 98

pharmaphorum

OCTOBER 12, 2022

As technology has evolved, biotech and pharmaceutical companies have increasingly leaned on AI to support drug development – including to make sense of the vast amounts of healthcare data available to them. By 2025, pharma’s investment in AI is expected to reach $3 billion. Forging an AI-enabled path toward precision medicine.

Immunization 105

Immunization Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

The Checkup by Singlecare

JANUARY 18, 2024

The patent protection for Nexplanon typically prevents other pharmaceutical companies from creating a generic version until the patent expires. in 2027 and other countries in 2025, when a generic version may be approved. Currently, there isn’t a generic equivalent available on the market.

Insurance 52

Insurance Insurance Coverage Packaging Pharmaceutical Companies 52

The Checkup by Singlecare

OCTOBER 27, 2023

The earliest date that a generic version could be available is in 2025. One place to start is to research any patient assistance program offered by the manufacturing pharmaceutical company, Bausch & Lomb. Related: Vyzulta side effects What is the generic for Vyzulta? Is Vyzulta covered by insurance?

Insurance 52

Insurance Pharmaceutical Companies Pharmaceutical Companies FDA 52

pharmaphorum

APRIL 19, 2022

“In a situation where most of the development of treatments in Korea is mostly centred on cancer and metabolic diseases, I noticed that there weren’t any companies that were focusing on sensory diseases.”. Kim says the Dry Eye Disease market is large and growing, with analysts predicting it will hit $6 billion USD by 2025.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication FDA 52

The Checkup by Singlecare

JUNE 6, 2024

This law enables Medicare to negotiate directly with pharmaceutical companies, which should ultimately result in lower prescription drug costs for consumers. Under the new law, there will also be a Part D out-of-pocket price cap of $2,000 starting in 2025.

Insurance 52

Insurance Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

The Checkup by Singlecare

JUNE 6, 2024

The law will allow Medicare to negotiate directly with pharmaceutical companies to improve access to affordable prescription drug costs. How the prescription drug law affects Jardiance In January 2023, a new prescription drug law went into effect as part of the Inflation Reduction Act.

Insurance 52

Insurance Vaccines Hospitals Pharmaceutical Companies 52

Viseven

AUGUST 29, 2024

Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. Pharmaceutical companies Pharmaceutical companies can transform their approaches to clinical trials with the help of 5G networks.

Communication 52

Communication Hospitals Insurance Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 19, 2023

Pharmaceutical companies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

JANUARY 4, 2023

As any new particular drug should be approved before becoming a consumable product, pharmaceutical companies must conduct research and drug trials during drug discovery. The post The Use of Artificial Intelligence in the Pharmaceutical Industry appeared first on Viseven.

Medical Records 52

Medical Records Pharmaceutical Companies Pharmaceutical Companies Communication 52

The Checkup by Singlecare

FEBRUARY 10, 2025

The pharmaceutical company Prasco currently markets a generic version of Farxiga. Additionally, several other companies have tentative FDA approvals, meaning that their generic versions have met the requirements for FDA approval but cannot yet be marketed in the United States due to patent issues.

Dosage 52

Dosage Labelling Hospitals FDA 52

The Checkup by Singlecare

JUNE 7, 2024

Made by the pharmaceutical company Janssen Biotech, Inc., Stelara is an injectable prescription medication used to treat plaque psoriasis , psoriatic arthritis , Crohn’s disease , and ulcerative colitis. It works on proteins that affect the immune system, which helps improve symptoms such as inflammation.

Immunization 52

Immunization Dosage Vaccines FDA 52